BSEShyama Computronics and Servic· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 10 Aug, 2026 · 15:56 IST

WTD and CFO resigns; new CFO appointed; Q1 results approved

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
₹3.82
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Pharmaceuticals peers, median of 165sector-0.4%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.2—+0.1—
Next day
—+0.2—-0.4—
2d
—+0.4—+0.1—
3d
-5.0+0.4-5.4-0.4-4.5
4d
-9.7+0.6-10.2-0.9-8.8
5d
-9.7+0.9-10.6-0.5-9.2
1w
-5.2+0.9-6.1-1.0-4.3
15d
-9.9+0.9-10.9-0.6-9.4
1m
-1.8+2.3-4.2+1.1-3.0
2m
—-1.1—-3.1—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On 10 Aug 2026, board approved Q1 FY27 standalone results - revenue from operations Rs 7.78 lakhs versus Rs 7.16 lakhs YoY; net profit Rs 0.65 lakhs versus Rs 1.28 lakhs. Mr Swaraj Kumar Singh resigned as Whole-Time Director and CFO citing pre-occupancy, effective same day. Ms Roshni Poddar appointed as new WTD and CFO for five years, subject to shareholder approval. 30th AGM set for 23 Sept 2026.

Likely market impact

Leadership churn at a micro-cap firm; Q1 profit nearly halved YoY on flat revenue. Short-term uncertainty from CFO transition.